Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway

L. J. Bugaj, A. J. Sabnis, A. Mitchell, J. E. Garbarino, J. E. Toettcher, T. G. Bivona, W. A. Lim

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences